Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
35
datasets available to search
ShareScore release 0.9.0
Dataset results
35 results for “smallpox vaccination”
A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
ClinicalTrials.gov study NCT00316602. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
ClinicalTrials.gov study NCT01144637. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
ClinicalTrials.gov study NCT01913353. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
ClinicalTrials.gov study NCT00857493. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
ClinicalTrials.gov study NCT02038881. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects
ClinicalTrials.gov study NCT00316524. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
ClinicalTrials.gov study NCT00316589. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders
ClinicalTrials.gov study NCT00189917. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
ClinicalTrials.gov study NCT00189956. IPD Sharing: NO. Countries: 1. Publications: 1.
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
ClinicalTrials.gov study NCT02977715. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox
ClinicalTrials.gov study NCT00053742. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults
ClinicalTrials.gov study NCT00026611. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Ort
ClinicalTrials.gov study NCT06549530. IPD Sharing: NO. Countries: 2. Publications: 0.
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
ClinicalTrials.gov study NCT00189904. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Trial of Smallpox Vaccine
ClinicalTrials.gov study NCT00046397. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Immune Responses to Smallpox Vaccination
ClinicalTrials.gov study NCT00325975. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers
ClinicalTrials.gov study NCT00103584. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
ClinicalTrials.gov study NCT00053495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults
ClinicalTrials.gov study NCT00053482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
ClinicalTrials.gov study NCT01668537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.